We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Omnitrope Application May Not Meet Current EC Regulations, Expert Says
Omnitrope Application May Not Meet Current EC Regulations, Expert Says
March 21, 2006
Sandoz’ application to market its generic human growth hormone Omnitrope may not meet the European Commission’s (EC) current regulatory pathway for follow-on biologics, according to an expert who adds the EC will likely approve the product anyway.